Expertise in
83
conditions

Hao G. Xu

State Key Laboratory Of Drug Research, 
Shanghai, CN 
Expertise in
83
conditions
State Key Laboratory Of Drug Research, 
Shanghai, CN 

Overview

Hao Xu practices practicing medicine in Shanghai, China.

Mr. Xu is highly rated in 83 conditions, according to our data. His clinical expertise encompasses Glioma, Gliomatosis Cerebri, Ampullary Cancer, Endoscopy, and Thymectomy.

He is actively involved in clinical research, co-authoring 2984 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

State Key Laboratory Of Drug Research, Shanghai, China
Other Locations
168 Changhai Road, Shanghai, 200433, China
Union Hospital, Wuhan, 430022, China
Shanghai Sixth People's Hospital Jinshan Branch
Shanghai, 201599, China
Nanjing Street 155, Shenyang, 110001, China
No. 613 West Huangpu Road, Guangzhou, 510630, China
300 Guangzhou Road, Nanjing, 210009, China
725 Wan Ping South Road, Shanghai, 200032, China
1095 Jie Fang Ave, Wuhan, 430030, China
San Xiang Road 1055, Suzhou, 215006, China
Xueyuan Road 270, Wenzhou, 325027, China
No.6 Fucheng Road, Beijing, 100048, China
28 Xianning West Road, Xi'an, 710049, China
No. 96, Jinzhai Road, Hefei, 230026, China
No. 54 Youdian Road, Hangzhou, China
188 Shizi Street, Suzhou, 215006, China
26 Hexing Road, Harbin, 150040, China
No. 300 Guangzhou Rd, Nanjing, 210009, China
12 Urumqi Road, Shanghai, 200040, China
899 Pinghai Road, Suzhou, 215007, China
500 Dongchuan Road, Shanghai, 200241, China
No. 613, West Huangpu Avenue, Guangzhou, 510630, China
3-11 Wenhua Road, Shenyang, 110819, China
No. 55, 4th Section Of South Ren Min Road, Chengdu, 610041, China
No. 8 Xishiku Street, Beijing, 100034, China
68 Xuefu South Road, Wuhan, 430023, China
8 Xi ShiKu Street, Beijing, 100034, China
No. 2800, Gongwei Road, Pudong, 201399, China
No. 1, Donggang West Road, Lanzhou, 730000, China
99 West Huaihai Road, Xuzhou, 221006, China
44 Wenhua West Road, Jinan, China
No. 59, Haier Road, Qingdao, 266000, China
No.39 Yunwushan Road, Changning, 200051, China
NO.1095 Jie Fang Avenue, Wuhan, 430030, China
The Affiliated Hospital of Xuzhou Medical University
Xuzhou, China
189 South Jiuhua Road, Wuhu, 241002, China
28 Fuxing Road, Haidian, China
166 Mianxing West Road, Mianyang, 621000, China
27397, Jingshi Rd, Jinan, China
No. 156 Xi'er Huang Road, Fuzhou, 350025, China
1200 Cailun Road, Shanghai, 201203, China
120 Dongling Road, Shenyang, 110866, China
1 East Beijing Road, Wuhu, 241000, China
No.5 Yiheyuan Road, Haidian, 100871, China
99 Huaihaixi Road, Xuzhou, 221002, China
No 7, Weiwu Road, Zhengzhou, 450003, China
No. 37 Guo Xue Xiang Street, 610041, Chengdu, China
Zhongshan North Road 34, Quanzhou, 362000, China
Desheng Middle Road 298, Hangzhou, 310021, China
College Of Resources Science Of Land, Baoding, 071001, China
Second Hospital Of Tianjin Medical UniversityPingjiang Road 23, Dayingmen, 300211, China
826 Zhangheng Road, 201203, Shanghai, China
P.r, Jinan, China
600 Yi Shan Road, Shanghai, 200233, China
5625 Renmin Street, Changchun, 130022, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Comparion of 22G-ProCore and 22G-Standard Needle in Diagnosis of Lymphadenopathy Via EBUS-TBNA: A Prospective, Single-center, Randomized Controlled Clinical Trial
Comparion of 22G-ProCore and 22G-Standard Needle in Diagnosis of Lymphadenopathy Via EBUS-TBNA: A Prospective, Single-center, Randomized Controlled Clinical Trial
Enrollment Status: Unknown
Publish Date: September 29, 2022
Intervention Type: Device
Study Phase: Not Applicable

2977 Total Publications

Genome-wide CRISPR screen identifies ELFN2 as a key regulator of host autophagy and lipid metabolism important for Toxoplasma gondii proliferation.
Genome-wide CRISPR screen identifies ELFN2 as a key regulator of host autophagy and lipid metabolism important for Toxoplasma gondii proliferation.
Journal: Autophagy
Published: June 22, 2026

Frequently Asked Questions about Hao G. Xu

Is Hao G. Xu a top-rated expert for Glioma?

MediFind is an objective health platform that identifies experts based on real-world data. Hao G. Xu is classified as an Elite expert for Glioma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Hao G. Xu participate in research or clinical trials?

Yes. Hao G. Xu has published 2977 articles and abstracts on conditions like Glioma. You can view a list of Hao G. Xu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Xu's expertise for a condition
ConditionClose
View All 16 Distinguished Conditions
View All 65 Advanced Conditions
View All 292 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile